<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01936142</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-13-0167-YMICH</org_study_id>
    <nct_id>NCT01936142</nct_id>
  </id_info>
  <brief_title>The Use of Renal Guard System in Patients Undergoing CRT Implantation</brief_title>
  <official_title>The Effect of Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During CRT Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of RenalGuard system which creates
      high urine output with fluid balancing may prevent contrast induced nephropathy in patient
      undergoing cardiac resynchronization therapy (CRT) implantation.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No suitable patient found
  </why_stopped>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Renal function</measure>
    <time_frame>24 and 48 hours post implantation and 8-11 days post implantation, 6 month post implantaion</time_frame>
    <description>Change in Renal function will be measured by change in serum creatinine (mg/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular lead implantation success</measure>
    <time_frame>1 day post implantation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalization due to infection</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>No RenalGuard</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will undergo CRT implantation without using RenalGuard</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RenalGuard</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the RenalGuard system during CRT implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of RenalGuard</intervention_name>
    <arm_group_label>RenalGuard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. eligible for CRT implantation

          2. estimated GFR &lt; 60ml/min/1.73m2

        Exclusion Criteria:

          1. On Dialysis

          2. Sensitivity to Furosemide

          3. Contraindication for urinary catheter

          4. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoav Michowich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Sourasky MC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Souraky MC</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2013</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>July 6, 2016</last_update_submitted>
  <last_update_submitted_qc>July 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>michal roll</investigator_full_name>
    <investigator_title>Head of Research and Development Division</investigator_title>
  </responsible_party>
  <keyword>Resynchroniztion therapy</keyword>
  <keyword>Kidney</keyword>
  <keyword>Contrast media</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

